BIONTECH UK LIMITEDActive

Company number 13041271Private limited companyIncorporated 2020

Key figures

£878,165+762.3%
Net assets 2023
+696.7%
Average annual growth 2021–2023
0250 k500 k750 k1 m202120222023

BIONTECH UK LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.

Ratios

2023
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
05 m10 m15 m202120222023
Filed accounts2021–2023
202120222023
Profit for the year——765,162
Cash at bank and in hand459,268612,893546,050
Total assets782,7701,379,9529,684,216
Total liabilities768,9351,278,1139,315,274
Net assets / total equity13,835101,839878,165
Average number of employees51044

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2023

Manufacture of pharmaceutical preparations

As described in the company's latest filed accounts.

Summary: BIONTECH UK LIMITED

Company

BIONTECH UK LIMITED is a private limited company registered with Companies House under company number 13041271. It was incorporated on 24 Nov 2020. Its status is active. The registered office is in London (NW1). Its nature of business (SIC 2007) is manufacture of pharmaceutical preparations (21200), research and experimental development on biotechnology (72110).

Accounts

The latest accounts in the database are for 2023 (period ending 31 Dec 2023); the company files small company accounts. Profit for the year was £765,162. Net assets were £878,165, up 762.3% on the previous year. Cash at bank and in hand was £546,050. Total assets were £9,684,216 and total liabilities £9,315,274. The company had an average of 44 employees. Figures are available for 3 financial years (2021–2023).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 7 Dec 2026.